158 related articles for article (PubMed ID: 9572303)
21. Characterization of NADPH-dependent ubiquinone reductase activity in rat liver cytosol: effect of various factors on ubiquinone-reducing activity and discrimination from other quinone reductases.
Takahashi T; Okamoto T; Kishi T
J Biochem; 1996 Feb; 119(2):256-63. PubMed ID: 8882715
[TBL] [Abstract][Full Text] [Related]
22. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
[TBL] [Abstract][Full Text] [Related]
23. Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis.
Chen S; Clarke PE; Martino PA; Deng PS; Yeh CH; Lee TD; Prochaska HJ; Talalay P
Protein Sci; 1994 Aug; 3(8):1296-304. PubMed ID: 7527260
[TBL] [Abstract][Full Text] [Related]
24. Menadione- (2-methyl-1,4-naphthoquinone-) dependent enzymatic redox cycling and calcium release by mitochondria.
Frei B; Winterhalter KH; Richter C
Biochemistry; 1986 Jul; 25(15):4438-43. PubMed ID: 3092856
[TBL] [Abstract][Full Text] [Related]
25. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
26. Requirement for iron for the production of hydroxyl radicals by rat liver quinone reductase.
Dicker E; Cederbaum AI
J Pharmacol Exp Ther; 1993 Sep; 266(3):1282-90. PubMed ID: 7690400
[TBL] [Abstract][Full Text] [Related]
27. Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
Roberts JJ; Marchbank T; Kotsaki-Kovatsi VP; Boland MP; Friedlos F; Knox RJ
Biochem Pharmacol; 1989 Nov; 38(22):4137-43. PubMed ID: 2480794
[TBL] [Abstract][Full Text] [Related]
28. Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver.
Prochaska HJ; Talalay P; Sies H
J Biol Chem; 1987 Feb; 262(5):1931-4. PubMed ID: 2434474
[TBL] [Abstract][Full Text] [Related]
29. Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase.
Kim YH; Hwang JH; Noh JR; Gang GT; Tadi S; Yim YH; Jeoung NH; Kwak TH; Lee SH; Kweon GR; Kim JM; Shong M; Lee IK; Lee CH
Free Radic Biol Med; 2012 Mar; 52(5):880-8. PubMed ID: 22227174
[TBL] [Abstract][Full Text] [Related]
30. The Menadione-Mediated WST1 Reduction by Cultured Astrocytes Depends on NQO1 Activity and Cytosolic Glucose Metabolism.
Ehrke E; Steinmeier J; Stapelfeldt K; Dringen R
Neurochem Res; 2021 Jan; 46(1):88-99. PubMed ID: 31902045
[TBL] [Abstract][Full Text] [Related]
31. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
[TBL] [Abstract][Full Text] [Related]
32. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
33. NAD(P)H (quinone acceptor) oxidoreductase (DT-diaphorase)-mediated two-electron reduction of anthraquinone-based antitumour agents and generation of hydroxyl radicals.
Fisher GR; Gutierrez PL; Oldcorne MA; Patterson LH
Biochem Pharmacol; 1992 Feb; 43(3):575-85. PubMed ID: 1311584
[TBL] [Abstract][Full Text] [Related]
34. Flavodoxin:quinone reductase (FqrB): a redox partner of pyruvate:ferredoxin oxidoreductase that reversibly couples pyruvate oxidation to NADPH production in Helicobacter pylori and Campylobacter jejuni.
St Maurice M; Cremades N; Croxen MA; Sisson G; Sancho J; Hoffman PS
J Bacteriol; 2007 Jul; 189(13):4764-73. PubMed ID: 17468253
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
[TBL] [Abstract][Full Text] [Related]
36. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
[TBL] [Abstract][Full Text] [Related]
37. Roles of DT diaphorase in the genotoxicity of nitroaromatic compounds in human and fish cell lines.
Hasspieler BM; Haffner GD; Adeli K
J Toxicol Environ Health; 1997 Oct; 52(2):137-48. PubMed ID: 9310146
[TBL] [Abstract][Full Text] [Related]
38. Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism.
Cullen JJ; Hinkhouse MM; Grady M; Gaut AW; Liu J; Zhang YP; Weydert CJ; Domann FE; Oberley LW
Cancer Res; 2003 Sep; 63(17):5513-20. PubMed ID: 14500388
[TBL] [Abstract][Full Text] [Related]
39. Photodependent inhibition of rat liver NAD(P)H:quinone acceptor oxidoreductase by (A)-2-azido-NAD+ and (A)-8-azido-NAD.
Deng PS; Zhao SH; Iyanagi T; Chen SA
Biochemistry; 1991 Jul; 30(28):6942-8. PubMed ID: 1906347
[TBL] [Abstract][Full Text] [Related]
40. Cytosol-mediated reduction of resorufin: a method for measuring quinone oxidoreductase.
Nims RW; Prough RA; Lubet RA
Arch Biochem Biophys; 1984 Mar; 229(2):459-65. PubMed ID: 6422857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
